Onconetix implements 1-for-5 reverse stock split to maintain Nasdaq compliance

Onconetix, Inc.

Reverse stock split effective March 25, 2026 at 12:01 a.m. Eastern Time.
Ratio fixed at 1-for-5, reducing outstanding shares from ~3.6M to ~0.7M.
No fractional shares issued; cash compensation based on March 24 closing price.
CUSIP changes to 68237Q 302; stock trades under symbol ONCO on Nasdaq.
Split intended to meet Nasdaq's $1.00 minimum bid price listing requirement.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Onconetix, Inc.: Onconetix, Inc. filed an amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-5 reverse stock split, effective March 25, 2026 (effective 2026-03-25).

Change: charter amendment
Effective: 2026-03-25

Exact text from the filing

On March 24, 2026, the Company filed the Amendment to its Charter with the Secretary of State of the State of Delaware to effect the Reverse Stock Split.

View on SEC.gov

80 governance changes filed in the last 30 days. Browse all governance changes →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-034902

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.